Quality under pressure: Strengthening continuity amid geopolitical uncertainty
One of the most persistent risks facing Indian pharma manufacturers is the industry's heavy dependence on China for KSMs and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Indian Pharma Industry
US tariffs leave Indian pharma unaffected, industry voices relief
Trump’s new tariffs impose 26% duty on India, while pharma remains exempt. Industry experts weigh in on the impact
EY Parthenon – OPPI report claims India’s pharma sector set for rapid growth
The report titled ‘Viksit Bharat@2047: Transforming India from pharmacy of the world to pharma powerhouse for the world’ states…
Regulatory convergence is extremely important
Regulatory convergence is extremely important because the basis of all this is science. Science is an objective thing so it…
DCGI waives off local trials for drugs approved in well-regulated markets
The countries on the list include the US, UK, Japan, Australia, Canada and the EU
Decoding Budget 2024-25: A lacklustre budget for pharma
The Finance Minister announced the Budget for 2024-25 on July 23, during the Monsoon Session of Parliament
Indian pharma industry in 21st century – What has changed for domestic supply?
Dr Ashok Omray, Pharma Consultant, points out that despite significant advancements, the Indian pharma industry grapples with…
Reimagining healthcare professionals engagement with omnichannel experiences
By Akash Kedia, MD and Lead – Life Sciences, Accenture in India and
Vinita Vasanth, MD and Commercial Lead - Life Sciences,…
Cracking the code – Generic vs. Brand Medicines
Dr Suresh Saravdekar, Former Assistant Director, Ministry of Medical Education & Research and Honorary Consultant, Institute…
The state of Indian pharma industry and expectations from budget
Navroz Mahudawala, Director, Candle Partners, looks into the key ongoing challenges for the Indian pharma industry and the…